160 related articles for article (PubMed ID: 8339624)
1. Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study.
Marik P; Kraus P; Sribante J; Havlik I; Lipman J; Johnson DW
Chest; 1993 Aug; 104(2):389-92. PubMed ID: 8339624
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic-mediated release of tumour necrosis factor alpha and norharman in patients with hospital-acquired pneumonia and septic encephalopathy.
Eggers V; Fügener K; Hein OV; Rommelspacher H; Heyes MP; Kox WJ; Spies CD
Intensive Care Med; 2004 Aug; 30(8):1544-51. PubMed ID: 15112034
[TBL] [Abstract][Full Text] [Related]
3. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study.
Confalonieri M; Urbino R; Potena A; Piattella M; Parigi P; Puccio G; Della Porta R; Giorgio C; Blasi F; Umberger R; Meduri GU
Am J Respir Crit Care Med; 2005 Feb; 171(3):242-8. PubMed ID: 15557131
[TBL] [Abstract][Full Text] [Related]
4. Hydrocortisone in Severe Community-Acquired Pneumonia.
Dequin PF; Meziani F; Quenot JP; Kamel T; Ricard JD; Badie J; Reignier J; Heming N; Plantefève G; Souweine B; Voiriot G; Colin G; Frat JP; Mira JP; Barbarot N; François B; Louis G; Gibot S; Guitton C; Giacardi C; Hraiech S; Vimeux S; L'Her E; Faure H; Herbrecht JE; Bouisse C; Joret A; Terzi N; Gacouin A; Quentin C; Jourdain M; Leclerc M; Coffre C; Bourgoin H; Lengellé C; Caille-Fénérol C; Giraudeau B; Le Gouge A;
N Engl J Med; 2023 May; 388(21):1931-1941. PubMed ID: 36942789
[TBL] [Abstract][Full Text] [Related]
5. [Prolonged infusion of hydrocortisone in patients with severe community acquired pneumonia].
Confalonieri M; Trevisan R
Recenti Prog Med; 2006 Jan; 97(1):32-6. PubMed ID: 16535928
[TBL] [Abstract][Full Text] [Related]
6. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.
Torres A; Sibila O; Ferrer M; Polverino E; Menendez R; Mensa J; Gabarrús A; Sellarés J; Restrepo MI; Anzueto A; Niederman MS; Agustí C
JAMA; 2015 Feb; 313(7):677-86. PubMed ID: 25688779
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.
Ramírez P; Ferrer M; Martí V; Reyes S; Martínez R; Menéndez R; Ewig S; Torres A
Crit Care Med; 2011 Oct; 39(10):2211-7. PubMed ID: 21705887
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.
Abraham E; Wunderink R; Silverman H; Perl TM; Nasraway S; Levy H; Bone R; Wenzel RP; Balk R; Allred R
JAMA; 1995 Mar 22-29; 273(12):934-41. PubMed ID: 7884952
[TBL] [Abstract][Full Text] [Related]
9. Patterns of cytokine expression in community-acquired pneumonia.
Puren AJ; Feldman C; Savage N; Becker PJ; Smith C
Chest; 1995 May; 107(5):1342-9. PubMed ID: 7750329
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein. A clinical marker in community-acquired pneumonia.
Smith RP; Lipworth BJ; Cree IA; Spiers EM; Winter JH
Chest; 1995 Nov; 108(5):1288-91. PubMed ID: 7587431
[TBL] [Abstract][Full Text] [Related]
11. [The effect of continuous renal replacement therapy on the outcome of severe pneumonia in patients receiving long-term immunosuppressants].
Zha Y; Yang X; Yuan J; Lin X; Shen Y; Hu Y; Zhang XY
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):169-72. PubMed ID: 23856137
[TBL] [Abstract][Full Text] [Related]
12. Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months.
Lassi ZS; Imdad A; Bhutta ZA
Cochrane Database Syst Rev; 2015 Jun; (6):CD008032. PubMed ID: 26077639
[TBL] [Abstract][Full Text] [Related]
13. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.
Abraham E; Glauser MP; Butler T; Garbino J; Gelmont D; Laterre PF; Kudsk K; Bruining HA; Otto C; Tobin E; Zwingelstein C; Lesslauer W; Leighton A
JAMA; 1997 May; 277(19):1531-8. PubMed ID: 9153367
[TBL] [Abstract][Full Text] [Related]
14. Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia.
Lee YL; Chen W; Chen LY; Chen CH; Lin YC; Liang SJ; Shih CM
J Crit Care; 2010 Mar; 25(1):176.e7-13. PubMed ID: 19592208
[TBL] [Abstract][Full Text] [Related]
15. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria.
Angus DC; Marrie TJ; Obrosky DS; Clermont G; Dremsizov TT; Coley C; Fine MJ; Singer DE; Kapoor WN
Am J Respir Crit Care Med; 2002 Sep; 166(5):717-23. PubMed ID: 12204871
[TBL] [Abstract][Full Text] [Related]
16. IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients.
Bacci MR; Leme RC; Zing NP; Murad N; Adami F; Hinnig PF; Feder D; Chagas AC; Fonseca FL
Braz J Med Biol Res; 2015 May; 48(5):427-32. PubMed ID: 25714883
[TBL] [Abstract][Full Text] [Related]
17. Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial.
Asehnoune K; Seguin P; Allary J; Feuillet F; Lasocki S; Cook F; Floch H; Chabanne R; Geeraerts T; Roger C; Perrigault PF; Hanouz JL; Lukaszewicz AC; Biais M; Boucheix P; Dahyot-Fizelier C; Capdevila X; Mahe PJ; Le Maguet P; Paugam-Burtz C; Gergaud S; Plaud B; Constantin JM; Malledant Y; Flet L; Sebille V; Roquilly A;
Lancet Respir Med; 2014 Sep; 2(9):706-16. PubMed ID: 25066331
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
[TBL] [Abstract][Full Text] [Related]
19. Serum tumor necrosis factor levels in patients with infectious disease and septic shock.
Offner F; Philippé J; Vogelaers D; Colardyn F; Baele G; Baudrihaye M; Vermeulen A; Leroux-Roels G
J Lab Clin Med; 1990 Jul; 116(1):100-5. PubMed ID: 2376691
[TBL] [Abstract][Full Text] [Related]
20. Severe community-acquired pneumonia treated with β-lactam-respiratory quinolone vs. β-lactam-macrolide combination.
Karhu J; Ala-Kokko TI; Ohtonen P; Syrjälä H
Acta Anaesthesiol Scand; 2013 May; 57(5):587-93. PubMed ID: 23379766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
